Suppr超能文献

沙眼与抗生素使用:SAFE 中的“抗生素”。

Trachoma and antibiotic use: the 'A' in SAFE.

机构信息

Wilmer RM 129, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD 21205, USA.

出版信息

Expert Rev Anti Infect Ther. 2012 Jan;10(1):75-83. doi: 10.1586/eri.11.150.

Abstract

Trachoma, a chronic conjunctivitis caused by Chlamydia trachomatis, is the leading infectious cause of blindness worldwide. In recognition of this public health problem, the World Health Assembly has targeted the year 2020 to eliminate blinding trachoma, and a multifaceted strategy (SAFE) is recommended, including antibiotics for treatment of infection. Trachoma is a disease of entire communities, and the pool of infection resides largely in preschool age children. Thus, for endemic communities, mass treatment with antibiotics annually for at least 3-5 years is carried out. The antibiotics used, the effectiveness of this approach, and the challenges of antibiotic treatment of communities are discussed, concluding with a view towards the elimination of trachoma in the future.

摘要

沙眼是由沙眼衣原体引起的慢性结膜炎,是全球致盲的主要传染病原因。认识到这一公共卫生问题,世界卫生大会已将 2020 年定为消除致盲性沙眼的目标,推荐了一种多方面的策略(SAFE),包括抗生素治疗感染。沙眼是整个社区的疾病,感染源主要存在于学龄前儿童中。因此,对于流行地区,每年至少进行 3-5 年的大规模抗生素治疗。本文讨论了所使用的抗生素、这种方法的有效性以及社区抗生素治疗的挑战,最后展望了未来消除沙眼的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验